US Stock MarketDetailed Quotes
VIR Vir Biotechnology
- 7.530
- +0.230+3.15%
Close Sep 27 16:00 ET
- 7.550
- +0.020+0.27%
Post 19:15 ET
1.03BMarket Cap-2103P/E (TTM)
7.610High7.400Low1.63MVolume7.420Open7.300Pre Close12.25MTurnover1.78%Turnover RatioLossP/E (Static)136.64MShares13.09052wk High0.72P/B689.20MFloat Cap7.20552wk Low--Dividend TTM91.53MShs Float141.010Historical High--Div YieldTTM2.88%Amplitude7.205Historical Low7.506Avg Price1Lot Size
Vir Biotechnology Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 107.40%941K | 9.62%51.2M | -97.50%39.49M | -55.93%9.6M | -101.10%-4.1M | 70.20%-12.72M | -96.20%46.71M | 45.39%1.58B | -97.31%21.79M | 261.62%371.43M |
| Operating revenue | -10.97%941K | 9.62%51.2M | -97.50%39.49M | -55.93%9.6M | -101.10%-4.1M | 102.48%1.06M | -96.20%46.71M | 45.39%1.58B | -97.31%21.79M | 261.62%371.43M |
| Cost of revenue | 136.36%52K | -96.91%59K | -98.11%2.77M | -86.69%798K | -99.83%38K | -99.92%22K | -97.88%1.91M | 122.15%146.32M | -89.46%6M | 183.98%22.25M |
| Gross profit | 106.98%889K | 14.15%51.15M | -97.44%36.73M | -44.25%8.8M | -101.18%-4.14M | 81.95%-12.74M | -96.07%44.81M | 40.44%1.43B | -97.90%15.79M | 268.03%349.18M |
| Operating expense | -32.39%133.24M | -30.26%131.23M | 19.96%721.03M | -11.11%147.82M | 18.40%182.6M | 27.46%197.08M | 49.39%188.18M | 0.11%601.09M | -8.19%166.3M | 4.02%154.22M |
| Selling and administrative expenses | -33.50%30.27M | -22.46%36.27M | 10.07%178.05M | 11.22%43.09M | -4.85%41.08M | 9.43%45.51M | 22.28%46.78M | 0.60%161.76M | -30.54%38.74M | -14.50%43.17M |
| Research and development costs | -37.46%105.11M | -36.49%100.13M | 24.23%589.67M | -27.88%111.92M | 29.86%148.25M | 46.05%168.08M | 74.72%157.64M | 5.95%474.65M | 20.91%155.17M | 15.71%114.17M |
| Other operating expenses | 87.08%-2.13M | 68.16%-5.17M | -32.16%-46.69M | 73.99%-7.19M | -115.58%-6.74M | -702.67%-16.52M | -544.39%-16.25M | -323.21%-35.33M | -823.47%-27.62M | -246.07%-3.13M |
| Operating profit | 36.92%-132.36M | 44.14%-80.08M | -182.14%-684.31M | 7.63%-139.02M | -195.78%-186.73M | 6.84%-209.82M | -114.14%-143.37M | 98.00%833.07M | -126.32%-150.5M | 465.20%194.96M |
| Net non-operating interest income expense | -18.12%18.85M | -0.11%21.28M | 209.66%86.99M | 28.22%20.74M | 135.01%21.93M | 946.18%23.02M | 5,391.49%21.31M | 6,299.09%28.09M | 9,583.83%16.17M | 84,736.36%9.33M |
| Non-operating interest income | -18.12%18.85M | -0.11%21.28M | 209.66%86.99M | 28.22%20.74M | 135.01%21.93M | 946.18%23.02M | 5,391.49%21.31M | 6,299.09%28.09M | 9,583.83%16.17M | 84,736.36%9.33M |
| Other net income (expense) | -143.84%-26.38M | 70.64%-6.2M | 71.11%-30.88M | 85.69%-2.48M | -113.58%-1.83M | -1.12%-10.82M | 77.12%-21.12M | -183.10%-106.88M | 33.51%-17.31M | -91.81%13.44M |
| Gain on sale of security | 108.43%429K | 54.86%-5.92M | 80.31%-21.89M | -111.17%-992K | 80.08%-2.71M | 55.35%-5.09M | 86.21%-13.1M | -180.51%-111.14M | 134.12%8.88M | -108.28%-13.59M |
| Special income (charges) | -389.66%-26.28M | ---- | ---- | ---- | ---- | ---5.37M | ---- | ---- | ---- | ---- |
| -Less：Restructuring and merger&acquisition | 389.66%26.28M | ---- | ---- | ---- | ---- | --5.37M | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | -45.78%-535K | 96.42%-287K | -311.06%-8.99M | 94.33%-1.49M | -96.74%882K | -153.11%-367K | -393.81%-8.02M | 145.14%4.26M | -374,000.00%-26.19M | 42,128.13%27.03M |
| Income before tax | 29.21%-139.89M | 54.61%-65M | -183.28%-628.19M | 20.36%-120.76M | -176.53%-166.63M | 15.44%-197.62M | -115.53%-143.19M | 37.19%754.28M | -127.78%-151.64M | 96.58%217.73M |
| Income tax | 46.91%-1.51M | 112.37%276K | -105.48%-13.08M | 90.44%-4.78M | -107.57%-3.21M | 98.19%-2.85M | -100.55%-2.23M | 1,023.78%238.44M | -342.48%-50.04M | 12,600.60%42.42M |
| Net income | 28.95%-138.38M | 53.69%-65.28M | -219.25%-615.12M | -14.14%-115.97M | -193.21%-163.41M | -154.63%-194.78M | -127.18%-140.96M | -2.41%515.84M | -119.34%-101.6M | 58.76%175.31M |
| Net income continuous Operations | 28.95%-138.38M | 53.69%-65.28M | -219.25%-615.12M | -14.14%-115.97M | -193.21%-163.41M | -154.63%-194.78M | -127.18%-140.96M | -2.41%515.84M | -119.34%-101.6M | 58.76%175.31M |
| Minority interest income | 0 | 0 | -56K | 0 | 0 | 0 | -56K | 0 | 0 | 0 |
| Net income attributable to the parent company | 28.95%-138.38M | 53.67%-65.28M | -219.24%-615.06M | -14.14%-115.97M | -193.21%-163.41M | -154.63%-194.78M | -127.17%-140.9M | -2.41%515.84M | -119.34%-101.6M | 58.76%175.31M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 28.95%-138.38M | 53.67%-65.28M | -219.24%-615.06M | -14.14%-115.97M | -193.21%-163.41M | -154.63%-194.78M | -127.17%-140.9M | -2.41%515.84M | -119.34%-101.6M | 58.76%175.31M |
| Basic earnings per share | 29.66%-1.02 | 54.72%-0.48 | -217.99%-4.59 | -13.16%-0.86 | -192.42%-1.22 | -150.00%-1.45 | -126.97%-1.06 | -4.42%3.89 | -118.95%-0.76 | 55.29%1.32 |
| Diluted earnings per share | 29.66%-1.02 | 54.72%-0.48 | -219.84%-4.59 | -13.16%-0.86 | -193.85%-1.22 | -150.00%-1.45 | -127.53%-1.06 | -3.28%3.83 | -119.39%-0.76 | 58.54%1.3 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data